Literature DB >> 33723332

Epidemiology, clinical relevance and prognosis of staphylococci in hospital-acquired postoperative intra-abdominal infections: an observational study in intensive care unit.

Kévin Boussion1, Nathalie Zappella1, Nathalie Grall2,3,4, Lara Ribeiro-Parenti5,3,6, Grégory Papin1, Philippe Montravers7,8,9.   

Abstract

The pathogenic role of staphylococci in hospital-acquired postoperative intra-abdominal infections (HAIs) has never been evaluated. In a tertiary care university hospital, we assessed the clinical characteristics and outcomes of patients admitted to the intensive care unit for HAIs according to the presence of staphylococci (S-HAI) or their absence (nS-HAI) in peritoneal cultures. Patients with S-HAIs were compared to nS-HAIs patients. Overall, 380 patients were analyzed, including 87 (23%) S-HAI patients [29 Staphylococcus aureus (Sa-HAIs) and 58 coagulase-negative staphylococci (CoNS-HAIs)]. The clinical characteristics did not differ between the S-HAI and nS-HAI patients. Adequacy of empirical anti-infective therapy was achieved less frequently in the staphylococci group (54 vs 72%, respectively, p < 0.01). The 90-day (primary endpoint) and one-year mortality rates did not differ between these groups. The S-HAI patients had decreased rates of postoperative complication (p < 0.05). The adjusted analysis of the clinical outcomes reported a decreased frequency of surgical complications in the staphylococci group (OR 0.43, 95% CI [0.20-0.93], p = 0.03). While the trends toward decreased morbidity criteria were observed in S-HAI patients, the clinical outcomes were not different between the CoNS-HAI and Sa-HAI patients. In summary, our data are not substantial enough to conclude that staphylococci exhibit no pathogenicity in HAIs.

Entities:  

Mesh:

Substances:

Year:  2021        PMID: 33723332      PMCID: PMC7960962          DOI: 10.1038/s41598-021-85443-8

Source DB:  PubMed          Journal:  Sci Rep        ISSN: 2045-2322            Impact factor:   4.379


  29 in total

Review 1.  Are coagulase-negative staphylococci virulent?

Authors:  C Heilmann; W Ziebuhr; K Becker
Journal:  Clin Microbiol Infect       Date:  2018-11-29       Impact factor: 8.067

2.  Multidrug-resistant, extensively drug-resistant and pandrug-resistant bacteria: an international expert proposal for interim standard definitions for acquired resistance.

Authors:  A-P Magiorakos; A Srinivasan; R B Carey; Y Carmeli; M E Falagas; C G Giske; S Harbarth; J F Hindler; G Kahlmeter; B Olsson-Liljequist; D L Paterson; L B Rice; J Stelling; M J Struelens; A Vatopoulos; J T Weber; D L Monnet
Journal:  Clin Microbiol Infect       Date:  2011-07-27       Impact factor: 8.067

3.  Therapeutic management of peritonitis: a comprehensive guide for intensivists.

Authors:  P Montravers; S Blot; G Dimopoulos; C Eckmann; P Eggimann; X Guirao; J A Paiva; G Sganga; J De Waele
Journal:  Intensive Care Med       Date:  2016-03-16       Impact factor: 17.440

4.  Guidelines for management of intra-abdominal infections.

Authors:  Philippe Montravers; Hervé Dupont; Marc Leone; Jean-Michel Constantin; Paul-Michel Mertes; Pierre-Francois Laterre; Benoit Misset; Jean-Pierre Bru; Rémy Gauzit; Albert Sotto; Cecile Brigand; Antoine Hamy; Jean-Jacques Tuech
Journal:  Anaesth Crit Care Pain Med       Date:  2015-04-24       Impact factor: 4.132

5.  Peritoneal dialysis-related peritonitis due to coagulase-negative Staphylococcus: a review of 115 cases in a Brazilian center.

Authors:  Carlos Henrique Camargo; Maria de Lourdes Ribeiro de Souza da Cunha; Jacqueline Costa Teixeira Caramori; Alessandro Lia Mondelli; Augusto Cezar Montelli; Pasqual Barretti
Journal:  Clin J Am Soc Nephrol       Date:  2014-03-27       Impact factor: 8.237

6.  The microbiology of postoperative peritonitis.

Authors:  A Roehrborn; L Thomas; O Potreck; C Ebener; C Ohmann; P E Goretzki; H D Röher
Journal:  Clin Infect Dis       Date:  2001-09-24       Impact factor: 9.079

7.  Enterococci increase the morbidity and mortality associated with severe intra-abdominal infections in elderly patients hospitalized in the intensive care unit.

Authors:  Hervé Dupont; Arnaud Friggeri; Jérémy Touzeau; Norair Airapetian; François Tinturier; Eric Lobjoie; Emmanuel Lorne; Moustafa Hijazi; Jean-Marc Régimbeau; Yazine Mahjoub
Journal:  J Antimicrob Chemother       Date:  2011-07-25       Impact factor: 5.790

8.  Methicillin-resistant Staphylococcus aureus as a causative agent of postoperative intra-abdominal infection: relation to nasal colonization.

Authors:  L Fierobe; D Decré; C Mùller; J C Lucet; J P Marmuse; J Mantz; J M Desmonts
Journal:  Clin Infect Dis       Date:  1999-11       Impact factor: 9.079

9.  Initial microbial spectrum in severe secondary peritonitis and relevance for treatment.

Authors:  O van Ruler; J J S Kiewiet; R J van Ketel; M A Boermeester
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2011-07-29       Impact factor: 3.267

10.  Epidemiology of intra-abdominal infection and sepsis in critically ill patients: "AbSeS", a multinational observational cohort study and ESICM Trials Group Project.

Authors:  Stijn Blot; Massimo Antonelli; Kostoula Arvaniti; Koen Blot; Ben Creagh-Brown; Dylan de Lange; Jan De Waele; Mieke Deschepper; Yalim Dikmen; George Dimopoulos; Christian Eckmann; Guy Francois; Massimo Girardis; Despoina Koulenti; Sonia Labeau; Jeffrey Lipman; Fernando Lipovestky; Emilio Maseda; Philippe Montravers; Adam Mikstacki; José-Artur Paiva; Cecilia Pereyra; Jordi Rello; Jean-Francois Timsit; Dirk Vogelaers
Journal:  Intensive Care Med       Date:  2019-10-29       Impact factor: 17.440

View more
  2 in total

Review 1.  Antimicrobial Lessons From a Large Observational Cohort on Intra-abdominal Infections in Intensive Care Units.

Authors:  Dirk Vogelaers; Stijn Blot; Andries Van den Berge; Philippe Montravers
Journal:  Drugs       Date:  2021-05-26       Impact factor: 9.546

2.  Prognostic value of PD-1, PD-L1 and P53 in patients with non-small cell lung cancer after postoperative adjuvant chemoradiotherapy.

Authors:  Aizhong Qu; Jiliang Han; Jianfeng Zhu
Journal:  Am J Transl Res       Date:  2022-07-15       Impact factor: 3.940

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.